Perjeta 420 MG/14 ML vial 14ML

Ended Awarded

Contract number
SPE2DR26FFDM1
Awardee
Awarding agency
Obligated
$19,623

Award facts

Contract value 100% obligated
$19,623.24 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on July 1, 2026, for Perjeta (pertuzumab) 420 mg/14 mL vials, with a ceiling value of $19,623.24 and an ultimate completion date of July 23, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

PPV-G GEN V is a single-award indefinite delivery contract under which DMS Pharmaceutical serves as the sole regional prime vendor for pharmaceutical products and medical consumables supporting Department of Defense military healthcare facilities worldwide. Place of performance is Park Ridge, Illinois. DMS Pharmaceutical is a woman-owned small business.

Quick answers

Who was awarded contract SPE2DR26FFDM1?

SPE2DR26FFDM1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 1, 2026.

How much is contract SPE2DR26FFDM1 worth?

The government has obligated $19,623 on SPE2DR26FFDM1.

Is contract SPE2DR26FFDM1 an order under another contract?

Yes. SPE2DR26FFDM1 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.

Was contract SPE2DR26FFDM1 competed?

The extent of competition for SPE2DR26FFDM1 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award